Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Renal Cell 30Neoplasms 11Sarcoma 8Carcinoma, Non-Small-Cell Lung 8Breast Neoplasms 7Ovarian Neoplasms 6Neoplasm Metastasis 5Fallopian Tube Neoplasms 3Colorectal Neoplasms 3Recurrence 2Hemangiosarcoma 2Financial Stress 2Clear-cell metastatic renal cell carcinoma 2Carcinoma, Ovarian Epithelial 2Uterine Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Diseases 1Solid Tumours 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Prostatic Neoplasms 1Patient Preference 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms, Plasma Cell 1Melanoma 1Liver Neoplasms 1Leiomyosarcoma 1

Interventions

Paclitaxel 12atezolizumab 11Gemcitabine 9pembrolizumab 8Injections 6Carboplatin 6Irinotecan 5Docetaxel 5Cetuximab 5tocilizumab 4navitoclax 4Leucovorin 4Fluorouracil 4Bevacizumab 4olaparib 3cobimetinib 3Oxaliplatin 3Nivolumab 3zolbetuximab 2tumor necrosis factor-alpha, CNGRC fusion protein, human 2tivozanib 2tislelizumab 2spartalizumab 2ridaforolimus 2plocabulin 2obinutuzumab 2motesanib diphosphate 2liposomal doxorubicin 2linifanib 2lenvatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Solid Tumors × pazopanib × Clear all
NCT02354612 2021-02-15

Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial

Tracon Pharmaceuticals Inc.

No longer available
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡